A rating of 67 puts Fate Therapeutics Inc (FATE) near the top of the Biotechnology industry according to InvestorsObserver. Fate Therapeutics Inc's score of 67 means it scores higher than 67% of stocks in the industry. Fate Therapeutics Inc also received an overall rating of 42, putting it above 42% of all stocks. Biotechnology is ranked 113 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 42 means the stock is more attractive than 42 percent of stocks.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Fate Therapeutics Inc Stock Today?
Fate Therapeutics Inc (FATE) stock is trading at $72.77 as of 12:21 PM on Wednesday, May 12, a loss of -$5.23, or -6.71% from the previous closing price of $78.00. The stock has traded between $71.63 and $77.96 so far today. Volume today is light. So far 720,193 shares have traded compared to average volume of 972,200 shares.
Click Here to get the full Stock Score Report on Fate Therapeutics Inc (FATE) Stock.
